{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:48:46Z","timestamp":1791265726090,"version":"4.1.0"},"reference-count":28,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2022,5,1]]},"DOI":"10.1001\/jamasurg.2022.0143","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:07:21Z","timestamp":1646824041000},"page":"374","source":"Crossref","is-referenced-by-count":212,"title":["Survival After Hyperthermic Intraperitoneal Chemotherapy and Primary or Interval Cytoreductive Surgery in Ovarian Cancer"],"prefix":"10.1001","volume":"157","author":[{"given":"Myong Cheol","family":"Lim","sequence":"first","affiliation":[{"name":"Center for Gynecologic Cancer, National Cancer Center, Goyang, South Korea"},{"name":"Center for Clinical Trial, National Cancer Center, Goyang, South Korea"},{"name":"Division of Rare and Refractory Cancer, Research Institute, National Cancer Center, Goyang, South Korea"},{"name":"Department of Cancer Control and Policy, National Cancer Center, Goyang, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk-Joon","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boram","family":"Park","sequence":"additional","affiliation":[{"name":"Biostatistics Collaboration Team, National Cancer Center, Goyang, South Korea"},{"name":"Biomedical Statistics Center, Research Institute for Future Medicine, Samsung Medical Center, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heon Jong","family":"Yoo","sequence":"additional","affiliation":[{"name":"Center for Gynecologic Cancer, National Cancer Center, Goyang, South Korea"},{"name":"Chungnam National University School of Medicine, Dajeon, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong Woo","family":"Yoo","sequence":"additional","affiliation":[{"name":"Center for Gynecologic Cancer, National Cancer Center, Goyang, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Ho","family":"Nam","sequence":"additional","affiliation":[{"name":"Biostatistics Collaboration Team, National Cancer Center, Goyang, South Korea"},{"name":"HERINGS, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Yoon","family":"Park","sequence":"additional","affiliation":[{"name":"Center for Gynecologic Cancer, National Cancer Center, Goyang, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"HIPEC for Ovarian Cancer Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Soo","family":"Seo","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sokbom","family":"Kang","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Yeon","family":"Yun","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-Soon","family":"Cho","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ho","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Sung","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Sil","family":"Park","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Woon","family":"Lee","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Chan","family":"Park","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Min","family":"Park","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Sik","family":"Han","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seoung Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee Chul","family":"Yang","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Mog","family":"Lee","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bang Wool","family":"Eom","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Il","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Man","family":"Yoon","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Ju","family":"Choi","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Han","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Young","family":"Joung","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Kyung","family":"Seo","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Nam","family":"Joo","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Jung","family":"Song","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sae Hyun","family":"Park","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Chul","family":"Jung","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Jung","family":"Kim","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Won","family":"Park","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Yong","family":"Jeong","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Ho","family":"Yun","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohee","family":"Park","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E","family":"Bristow","sequence":"additional","affiliation":[{"name":"for the HIPEC for Ovarian Cancer Collaborators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"soi220004r1","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1016\/S1470-2045(19)30456-5","article-title":"Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.","volume":"20","author":"Arnold","year":"2019","journal-title":"Lancet Oncol"},{"issue":"2","key":"soi220004r2","doi-asserted-by":"publisher","first-page":"316","DOI":"10.4143\/crt.2021.290","article-title":"Prediction of cancer incidence and mortality in Korea, 2021.","volume":"53","author":"Jung","year":"2021","journal-title":"Cancer Res Treat"},{"issue":"10177","key":"soi220004r3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer.","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"soi220004r4","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer.","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"issue":"13","key":"soi220004r5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.2014.55.9898","article-title":"Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer: a gynecologic oncology group study.","volume":"33","author":"Tewari","year":"2015","journal-title":"J Clin Oncol"},{"issue":"11","key":"soi220004r6","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrclinonc.2015.177","article-title":"Chemotherapy: limited use of the intraperitoneal route for ovarian cancer-why?","volume":"12","author":"Markman","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"soi220004r7","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1634\/theoncologist.2008-0275","article-title":"The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer.","volume":"14","author":"Helm","year":"2009","journal-title":"Oncologist"},{"issue":"5","key":"soi220004r8","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1080\/02656736.2017.1283066","article-title":"Current status and future prospects of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) clinical trials in ovarian cancer.","volume":"33","author":"Cowan","year":"2017","journal-title":"Int J Hyperthermia"},{"issue":"3","key":"soi220004r9","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer.","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"soi220004r10","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1002\/cncr.v125.s24","article-title":"Hyperthermic intraperitoneal chemotherapy does not improve survival in advanced ovarian cancer.","volume":"125","author":"Vergote","year":"2019","journal-title":"Cancer"},{"issue":"4","key":"soi220004r11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1245\/s10434-008-0299-y","article-title":"Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study.","volume":"16","author":"Lim","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"20","key":"soi220004r12","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"4","key":"soi220004r13","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2017.28.e48","article-title":"Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer.","volume":"28","author":"Lim","year":"2017","journal-title":"J Gynecol Oncol"},{"issue":"2","key":"soi220004r14","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"issue":"20","key":"soi220004r15","doi-asserted-by":"publisher","first-page":"4054","DOI":"10.1200\/JCO.2001.19.20.4054","article-title":"Use of CA-125 to define progression of ovarian cancer in patients with persistently elevated levels.","volume":"19","author":"Rustin","year":"2001","journal-title":"J Clin Oncol"},{"issue":"14","key":"soi220004r16","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMc1802033","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer.","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"soi220004r17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"soi220004r18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/02656736.2017.1279757","article-title":"Targeting therapy-resistant cancer stem cells by hyperthermia.","volume":"33","author":"Oei","year":"2017","journal-title":"Int J Hyperthermia"},{"issue":"5","key":"soi220004r19","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study.","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"soi220004r20","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ygyno.2007.03.019","article-title":"Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery.","volume":"106","author":"Bae","year":"2007","journal-title":"Gynecol Oncol"},{"issue":"23","key":"soi220004r21","doi-asserted-by":"publisher","first-page":"2594","DOI":"10.1200\/JCO.21.00605","article-title":"Secondary cytoreduction and carboplatin hyperthermic intraperitoneal chemotherapy for platinum-sensitive recurrent ovarian cancer: an MSK Team Ovary phase II study.","volume":"39","author":"Zivanovic","year":"2021","journal-title":"J Clin Oncol"},{"issue":"6","key":"soi220004r22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000313823","article-title":"Residual cancer stem cells after interval cytoreductive surgery following neoadjuvant chemotherapy could result in poor treatment outcomes for ovarian cancer.","volume":"33","author":"Lim","year":"2010","journal-title":"Onkologie"},{"issue":"3","key":"soi220004r23","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2020.31.e34","article-title":"Microscopic diseases remain in initial disseminated sites after neoadjuvant chemotherapy for stage III\/IV ovarian, tubal, and primary peritoneal cancer.","volume":"31","author":"Tate","year":"2020","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"soi220004r24","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy.","volume":"7","author":"Goodman","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"soi220004r25","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.canlet.2015.08.028","article-title":"High response rates to neoadjuvant platinum-based therapy in ovarian cancer patients carrying germ-line BRCA mutation.","volume":"369","author":"Gorodnova","year":"2015","journal-title":"Cancer Lett"},{"issue":"1","key":"soi220004r26","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12885-019-5622-4","article-title":"Genomic profiling in ovarian cancer retreated with platinum based chemotherapy presented homologous recombination deficiency and copy number imbalances of CCNE1 and RB1 genes.","volume":"19","author":"da Costa","year":"2019","journal-title":"BMC Cancer"},{"issue":"6","key":"soi220004r27","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/bjc.2013.70","article-title":"BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.","volume":"108","author":"Lesnock","year":"2013","journal-title":"Br J Cancer"},{"issue":"24","key":"soi220004r28","doi-asserted-by":"publisher","first-page":"9851","DOI":"10.1073\/pnas.1101053108","article-title":"Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition.","volume":"108","author":"Krawczyk","year":"2011","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2789724\/jamasurgery_lim_2022_oi_220004_1652211197.21879.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T12:29:18Z","timestamp":1652272158000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2789724"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,5,1]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2022.0143","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,1]]}}}